Literature DB >> 22056718

Glycated hemoglobin in ST-elevation myocardial infarction without previously known diabetes: its short and long term prognostic role.

Chiara Lazzeri1, Serafina Valente, Marco Chiostri, Claudio Picariello, Paola Attanà, Gian Franco Gensini.   

Abstract

In 518 consecutive STEMI non-diabetic patients, glycated hemoglobin>6.5% was not associated with increased short and long term mortality, but was associated with higher admission glucose values, worse in-hospital glycemic control and a higher incidence of acute insulin resistance (HOMA index).
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22056718     DOI: 10.1016/j.diabres.2011.09.028

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  3 in total

Review 1.  Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Maria Grazia D'Alfonso; Gian Franco Gensini
Journal:  World J Cardiol       Date:  2014-04-26

2.  Analysis of risk factors of ST-segment elevation myocardial infarction in young patients.

Authors:  Wang Yunyun; Li Tong; Liu Yingwu; Liu Bojiang; Wang Yu; Hu Xiaomin; Li Xin; Peng Wenjin; JinFang Li
Journal:  BMC Cardiovasc Disord       Date:  2014-12-09       Impact factor: 2.298

3.  Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis.

Authors:  Wenjun Pan; Haining Lu; Baotao Lian; Pengda Liao; Liheng Guo; Minzhou Zhang
Journal:  Cardiovasc Diabetol       Date:  2019-12-11       Impact factor: 9.951

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.